FcRn Inhibitor Market is Predicted to Grow Rapidly During the Study Period (2020–2034)

Retrieved on: 2024-04-16 17:15:06

Tags for this article:

Immunology

Neonatal fragment crystallizable receptor

Click the tags to see associated articles and topics

FcRn Inhibitor Market is Predicted to Grow Rapidly During the Study Period (2020–2034). View article details on HISWAI: https://www.globenewswire.com/news-release/2024/04/16/2863993/0/en/FcRn-Inhibitor-Market-is-Predicted-to-Grow-Rapidly-During-the-Study-Period-2020-2034-DelveInsight.html

Summary

The article highlights the projected growth of the FcRn inhibitor market in the biopharma industry, focusing on autoimmune diseases such as myasthenia gravis. Emerging therapies and increasing healthcare investments in countries like the United States, Japan, and European nations are driving the market. The tags reflect the relevance of immunology and autoimmunity in the context of the development of novel biopharmaceuticals targeting the neonatal fragment crystallizable receptor.

Article found on: www.globenewswire.com

View Original Article